Dactinomycin
Get a Quick Quote Now
Select Packaging
Product Description
Product
Dactinomycin
CAS
50-76-0
Formula
C22H29FO4
Synonym
ActD Actinomycin C1 Actinomycin D Dactinomicina [INN-Spanish] Dactinomycine [INN-French] Dactinomycinum [INN-Latin], 1-N,9-N-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6,13-bis(propan-2-yl)-hexadecahydro-1H-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide
Typical Product Specifications
Molecular weight
1255.417
Assay/Purity
Typically NLT 98%
Chemical Structure
Notes
Dactinomycin is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
SMILES: [H][C,,]12CCCN1C(=O)[C,H](NC(=O)[C,,H](NC(=O)C1=C3N=C4C(OC3=C(C)C=C1)=C(C)C(=O)C(N)=C4C(=O)N[C,H]1[C,,H](C)OC(=O)[C,H](C(C)C)N(C)C(=O)CN(C)C(=O)[C,]3([H])CCCN3C(=O)[C,H](NC1=O)C(C)C)[C,,H](C)OC(=O)[C,H](C(C)C)N(C)C(=O)CN(C)C2=O)C(C)C
SMILES: [H][C,,]12CCCN1C(=O)[C,H](NC(=O)[C,,H](NC(=O)C1=C3N=C4C(OC3=C(C)C=C1)=C(C)C(=O)C(N)=C4C(=O)N[C,H]1[C,,H](C)OC(=O)[C,H](C(C)C)N(C)C(=O)CN(C)C(=O)[C,]3([H])CCCN3C(=O)[C,H](NC1=O)C(C)C)[C,,H](C)OC(=O)[C,H](C(C)C)N(C)C(=O)CN(C)C2=O)C(C)C
Class
Toxic Release Inventory (TRI) Chemicals , API Product List , Active Pharmaceutical Ingredients (API) & Intermediates
Industry
Dactinomycin
Product Description
Product
Dactinomycin
CAS
50-76-0
Formula
C22H29FO4
Synonym
ActD Actinomycin C1 Actinomycin D Dactinomicina [INN-Spanish] Dactinomycine [INN-French] Dactinomycinum [INN-Latin], 1-N,9-N-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6,13-bis(propan-2-yl)-hexadecahydro-1H-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide
Typical Product Specifications
Molecular weight
1255.417
Assay/Purity
Typically NLT 98%
Chemical Structure
Notes
Dactinomycin is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
SMILES: [H][C,,]12CCCN1C(=O)[C,H](NC(=O)[C,,H](NC(=O)C1=C3N=C4C(OC3=C(C)C=C1)=C(C)C(=O)C(N)=C4C(=O)N[C,H]1[C,,H](C)OC(=O)[C,H](C(C)C)N(C)C(=O)CN(C)C(=O)[C,]3([H])CCCN3C(=O)[C,H](NC1=O)C(C)C)[C,,H](C)OC(=O)[C,H](C(C)C)N(C)C(=O)CN(C)C2=O)C(C)C
SMILES: [H][C,,]12CCCN1C(=O)[C,H](NC(=O)[C,,H](NC(=O)C1=C3N=C4C(OC3=C(C)C=C1)=C(C)C(=O)C(N)=C4C(=O)N[C,H]1[C,,H](C)OC(=O)[C,H](C(C)C)N(C)C(=O)CN(C)C(=O)[C,]3([H])CCCN3C(=O)[C,H](NC1=O)C(C)C)[C,,H](C)OC(=O)[C,H](C(C)C)N(C)C(=O)CN(C)C2=O)C(C)C
Class
Toxic Release Inventory (TRI) Chemicals , API Product List , Active Pharmaceutical Ingredients (API) & Intermediates
Industry